{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:44:44Z","timestamp":1792089884939,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.eclinm.2021.101158","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T09:44:25Z","timestamp":1634636665000},"page":"101158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study"],"prefix":"10.1016","volume":"41","author":[{"given":"Galia","family":"Rahav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lavee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ohad Benjamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Magen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Hod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Noga Shem-Tov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat Shacham","family":"Shmueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Drorit Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Ben-Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Indenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liraz","family":"Olmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Huppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eytan","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-4607","authenticated-orcid":false,"given":"Gili","family":"Regev-Yochay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmit","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat Wieder-","family":"Finesod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-1293","authenticated-orcid":false,"given":"Itzchak","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.101158_bib0001","unstructured":"Johns Hopkins University Coronavirus Resource Center. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University. 2020 (https:\/\/coronavirus.jhu.edu\/map.html. opens in new tab)."},{"key":"10.1016\/j.eclinm.2021.101158_bib0002","unstructured":"Centers for Disease Control and Prevention. COVID-19 information page (https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/index.html. opens in new tab) 2021."},{"issue":"2","key":"10.1016\/j.eclinm.2021.101158_bib0003","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jamaoncol.2020.6178","article-title":"Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection","volume":"7","author":"Wang","year":"2021","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101158_bib0004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2021.101158_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/GO.20.00639","article-title":"Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review","volume":"7","author":"Riera","year":"2021","journal-title":"JCO Glob Oncol"},{"issue":"27","key":"10.1016\/j.eclinm.2021.101158_bib0006","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.101158_bib0007","unstructured":"Israel Ministry of Health. Coronavirus (COVID-10) vaccines https:\/\/www.health.gov.il\/UnitsOffice\/HD\/PH\/epidemiology\/td\/docs\/365_Corona.pdf. 2021"},{"key":"10.1016\/j.eclinm.2021.101158_bib0008","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.eclinm.2021.101158_bib0009","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2021.101158_bib0010","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.101158_bib0011","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2021.101158_bib0012","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(21)00502-X","article-title":"Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine","volume":"397","author":"Prendecki","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101158_bib0013","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","article-title":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals","volume":"397","author":"Manisty","year":"2021","journal-title":"Lancet"},{"issue":"10283","key":"10.1016\/j.eclinm.2021.101158_bib0014","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(21)00782-0","article-title":"Correlates of protection from SARS-CoV-2 infection","volume":"397","author":"Krammer","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101158_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100651","article-title":"Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation","volume":"29-30","author":"Oved","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101158_bib0016","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","article-title":"A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition","volume":"28","author":"Dieterle","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.eclinm.2021.101158_bib0017","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.eclinm.2021.101158_bib0018","doi-asserted-by":"crossref","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) Statement: guidelines for reporting observational studies (2008).","DOI":"10.1007\/s10049-008-1057-1"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101158_bib0019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/TP.0000000000003523","article-title":"COVID-19 and solid organ transplantation: a review article","volume":"105","author":"Azzi","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.eclinm.2021.101158_bib0020","article-title":"Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity","author":"Truong","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.eclinm.2021.101158_bib0021","article-title":"Immunogenicity of pneumococcal vaccination in HIV infected individuals: a systematic review and meta-analysis","volume":"29-30","author":"Garcia Garrido","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eclinm.2021.101158_bib0022","first-page":"ciab648","article-title":"BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with HIV","author":"Woldemeskel","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2021.101158_bib0023","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3389\/fimmu.2020.01917","article-title":"effect of influenza vaccination inducing antibody mediated rejection in solid organ transplant recipients","volume":"11","author":"Cordero","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.eclinm.2021.101158_bib0024","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.healun.2021.04.003","article-title":"BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response","volume":"40","author":"Peled","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.eclinm.2021.101158_bib0025","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.eclinm.2021.101158_bib0026","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.eclinm.2021.101158_bib0027","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European conference on infections in leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2021.101158_bib0028","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jtct.2021.06.024","article-title":"Safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients after allogeneic HCT or CD19-based CART therapy-A single-center prospective cohort study","volume":"27","author":"Ram","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.eclinm.2021.101158_bib0029","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2017.02.012","article-title":"Influenza vaccination in adult patients with solid tumours treated with chemotherapy","volume":"76","author":"Vollaard","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eclinm.2021.101158_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2155","article-title":"Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer","author":"Massarweh","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101158_bib0031","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-021-01090-6","article-title":"Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution","volume":"14","author":"Pimpinelli","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.eclinm.2021.101158_bib0032","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:08:35Z","timestamp":1762888115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021004387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":32,"alternative-id":["S2589537021004387"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101158","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101158"}}